These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19255786)

  • 1. Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.
    Abdul-Ghani R; Loutfy N; el-Sahn A; Hassan A
    Parasitol Res; 2009 Apr; 104(5):955-65. PubMed ID: 19255786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical therapy of schistosomiasis mansoni: the Brazilian contribution.
    Katz N; Coelho PM
    Acta Trop; 2008; 108(2-3):72-8. PubMed ID: 18617155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni.
    de Moraes J; de Oliveira RN; Costa JP; Junior AL; de Sousa DP; Freitas RM; Allegretti SM; Pinto PL
    PLoS Negl Trop Dis; 2014; 8(1):e2617. PubMed ID: 24392173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal.
    Danso-Appiah A; De Vlas SJ
    Trends Parasitol; 2002 Mar; 18(3):125-9. PubMed ID: 11854090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni: In vivo evaluation of Phyllanthus amarus hexanic and ethanolic extracts.
    de Oliveira CNF; Frezza TF; Garcia VL; Figueira GM; Mendes TMF; Allegretti SM
    Exp Parasitol; 2017 Dec; 183():56-63. PubMed ID: 29074138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Praziquantel--its use, cost and possible development of resistance.
    Kusel J; Hagan P
    Parasitol Today; 1999 Sep; 15(9):352-4. PubMed ID: 10461159
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiparasitic activity of nerolidol in a mouse model of schistosomiasis.
    Silva MP; de Oliveira RN; Mengarda AC; Roquini DB; Allegretti SM; Salvadori MC; Teixeira FS; de Sousa DP; Pinto PLS; da Silva Filho AA; de Moraes J
    Int J Antimicrob Agents; 2017 Sep; 50(3):467-472. PubMed ID: 28666754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
    Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
    Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance in schistosomiasis: a review.
    Bruce JI; Dias LC; Liang YS; Coles GC
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():143-50. PubMed ID: 3151088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.
    French MD; Churcher TS; Basáñez MG; Norton AJ; Lwambo NJ; Webster JP
    Acta Trop; 2013 Nov; 128(2):196-205. PubMed ID: 22440199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antischistosomal activity of trioxaquines: in vivo efficacy and mechanism of action on Schistosoma mansoni.
    Portela J; Boissier J; Gourbal B; Pradines V; Collière V; Coslédan F; Meunier B; Robert A
    PLoS Negl Trop Dis; 2012; 6(2):e1474. PubMed ID: 22348155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of Schistosoma mansoni to praziquantel: is there a problem?
    Doenhoff MJ; Kusel JR; Coles GC; Cioli D
    Trans R Soc Trop Med Hyg; 2002; 96(5):465-9. PubMed ID: 12474468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of treatment with a Protein Tyrosine Kinase Inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection.
    Sobhy MMK; Mahmoud SS; El-Sayed SH; Rizk EMA; Raafat A; Negm MSI
    Exp Parasitol; 2018 Feb; 185():115-123. PubMed ID: 29331278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies.
    Xiao SH
    Parasitol Res; 2013 Nov; 112(11):3723-40. PubMed ID: 23979493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does mass drug administration affect Schistosoma mansoni infection trends in West Dembia district, Northwest Ethiopia?
    Zeleke AJ; Addisu A; Bayih AG; Tweya H; Timire C; Techilo W; Kamau EM; Vogt F; Verdonck K
    J Infect Dev Ctries; 2020 Jun; 14(6.1):72S-77S. PubMed ID: 32614800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
    Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
    ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and activity of new triphenylphosphonium derivatives of betulin and betulinic acid against Schistosoma mansoni in vitro and in vivo.
    Spivak AY; Keiser J; Vargas M; Gubaidullin RR; Nedopekina DA; Shakurova ER; Khalitova RR; Odinokov VN
    Bioorg Med Chem; 2014 Nov; 22(21):6297-304. PubMed ID: 25245671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance or tolerance in schistosomes?
    Coles GC
    Trends Parasitol; 2002 Jul; 18(7):294. PubMed ID: 12379947
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug resistance to schistosomicides and other anthelmintics of medical significance.
    Brindley PJ
    Acta Trop; 1994 Mar; 56(2-3):213-31. PubMed ID: 8203304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro and in Vivo Antischistosomal Activities of Chalcones.
    Pereira VRD; Junior IJA; da Silveira LS; Geraldo RB; de F Pinto P; Teixeira FS; Salvadori MC; Silva MP; Alves LA; Capriles PVSZ; das C Almeida A; Coimbra ES; Pinto PLS; Couri MRC; de Moraes J; Da Silva Filho AA
    Chem Biodivers; 2018 Dec; 15(12):e1800398. PubMed ID: 30276965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.